HKAM
AVNS

Horizon Kinetics Asset Management’s Avanos Medical AVNS Stock Holding History

Horizon Kinetics Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-6,016
Closed -$203K – 387
2019
Q4 		$203K Sell
6,016
-72
-1% -$2.61K 0.01% 458
2019
Q3 		$228K Buy
6,088
+10
+0.2% +$381 0.01% 440
2019
Q2 		$265K Buy
6,078
+6
+0.1% +$257 0.01% 428
2019
Q1 		$259K Buy
+6,072
New +$272K 0.01% 434

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Horizon Kinetics Asset Management's AVNS Position: Q1 2020 in Review

Horizon Kinetics Asset Management sold out of Avanos Medical (AVNS) in Q1 2020, closing a stake of 6,016 shares — an estimated $203K sold.

Horizon Kinetics Asset Management first reported a position in AVNS in Q1 2019 and held it in 4 quarters. The position peaked at $265K in Q2 2019. 272 funds tracked by Wall St. Rank hold AVNS as of Q1 2020.

  • Horizon Kinetics Asset Management reported no remaining Avanos Medical position as of Q1 2020 after selling out during the quarter.
  • Horizon Kinetics Asset Management sold 6,016 Avanos Medical shares in Q1 2020, an estimated $203K.
  • Horizon Kinetics Asset Management first reported a position in Avanos Medical in Q1 2019 and held it in 4 quarters.
  • Horizon Kinetics Asset Management's Avanos Medical position peaked at $265K in Q2 2019.
  • 272 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2020.

Based on Horizon Kinetics Asset Management's 13F filing for Q1 2020, filed 13 May 2020.